Laser manufacturer Modulight Inc.
of Tampere, Finland, has designed, integrated and CE-certified an OEM medical laser system for PCI Biotech of Oslo, Norway, for a novel cancer therapy process. Under a multiyear OEM manufacturing agreement, Modulight will deliver a seven-channel medical laser system solution to PCI Biotech for its PCI (PhotoChemical Internalisation) patented photochemical drug delivery technology used for cancer therapy and other diseases. PCI is a technology for light-directed drug delivery by triggered endosomal release. It was developed to introduce therapeutic molecules in a biologically active form specifically into diseased cells.